Arvinder Dhalla

Member Board of Trustees

Arvinder Dhalla is a seasoned and forward-thinking scientist and leader, boasting over 20 years of exceptional experience in the Biotech and Med-tech sectors, with a particular focus on cardiovascular, endocrinology, and pulmonary arterial hypertension (PAH) therapeutic areas.

Throughout his illustrious career, Arvinder has proven himself as a results-oriented problem-solver, consistently driving innovation and successfully leading multiple drug development programs from early discovery stages to clinical development. His invaluable contributions extend to participating in the preparation and submission of investigational new drug (IND) and new drug (NDA) applications, leading to the approval of two groundbreaking drugs.

Talks About
#programmanagement #drugdiscovery

Preferred Locations
#Northamerica